ReShape Lifesciences Inc. (RSLS)
USD 0.38
(-15.62%)
USD 0.38
(-15.62%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 5.54 Million USD | -18.44% |
| 2022 | 6.8 Million USD | -18.52% |
| 2021 | 8.34 Million USD | 33.31% |
| 2020 | 6.26 Million USD | -32.7% |
| 2019 | 9.3 Million USD | 2003.25% |
| 2018 | 442.41 Thousand USD | 26.13% |
| 2017 | 350.76 Thousand USD | -1.24% |
| 2016 | 355.18 Thousand USD | 112.69% |
| 2015 | 167 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 80 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.16 Million USD | -36.75% |
| 2024 Q2 | 1.13 Million USD | -2.66% |
| 2023 Q3 | 1.28 Million USD | 7.87% |
| 2023 Q2 | 1.19 Million USD | -2.45% |
| 2023 Q1 | 1.22 Million USD | -23.5% |
| 2023 FY | 5.54 Million USD | -18.44% |
| 2023 Q4 | 1.84 Million USD | 43.01% |
| 2022 Q1 | 1.21 Million USD | -31.42% |
| 2022 Q2 | 1.88 Million USD | 54.6% |
| 2022 FY | 6.8 Million USD | -18.52% |
| 2022 Q4 | 1.6 Million USD | -23.85% |
| 2022 Q3 | 2.1 Million USD | 11.58% |
| 2021 Q2 | 2.15 Million USD | -5.74% |
| 2021 Q1 | 2.28 Million USD | 39.27% |
| 2021 Q3 | 2.13 Million USD | -0.84% |
| 2021 Q4 | 1.77 Million USD | -16.81% |
| 2021 FY | 8.34 Million USD | 33.31% |
| 2020 Q1 | 1.5 Million USD | -28.89% |
| 2020 FY | 6.26 Million USD | -32.7% |
| 2020 Q3 | 2.28 Million USD | 172.52% |
| 2020 Q4 | 1.64 Million USD | -28.1% |
| 2020 Q2 | 837 Thousand USD | -44.35% |
| 2019 Q3 | 2.1 Million USD | -26.43% |
| 2019 Q2 | 2.85 Million USD | 28.06% |
| 2019 FY | 9.3 Million USD | 2003.25% |
| 2019 Q4 | 2.11 Million USD | 0.62% |
| 2019 Q1 | 2.23 Million USD | 256.57% |
| 2018 Q3 | 86.3 Thousand USD | 364.15% |
| 2018 FY | 442.41 Thousand USD | 26.13% |
| 2018 Q1 | 121.04 Thousand USD | -22.49% |
| 2018 Q2 | 18.59 Thousand USD | -84.64% |
| 2018 Q4 | -1.42 Million USD | -1750.94% |
| 2017 Q1 | 10.51 Thousand USD | -79.97% |
| 2017 Q3 | 145.5 Thousand USD | 277.08% |
| 2017 Q2 | 38.58 Thousand USD | 266.91% |
| 2017 Q4 | 156.15 Thousand USD | 7.32% |
| 2017 FY | 350.76 Thousand USD | -1.24% |
| 2016 Q4 | 52.49 Thousand USD | -65.03% |
| 2016 FY | 355.18 Thousand USD | 112.69% |
| 2016 Q2 | 120.69 Thousand USD | 278.77% |
| 2016 Q1 | 31.86 Thousand USD | -59.15% |
| 2016 Q3 | 150.12 Thousand USD | 24.39% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | 78 Thousand USD | 91.86% |
| 2015 Q3 | 40.65 Thousand USD | -15.72% |
| 2015 Q2 | 48.23 Thousand USD | 0.0% |
| 2015 FY | 167 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2012 Q1 | 37.58 Thousand USD | 0.0% |
| 2012 Q3 | - USD | -100.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | 42 Thousand USD | 11.76% |
| 2012 FY | 80 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 276.857% |
| Cerus Corporation | 86.4 Million USD | 93.579% |
| OrthoPediatrics Corp. | 111.25 Million USD | 95.013% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -650.21% |
| Talis Biomedical Corporation | 371 Thousand USD | -1395.418% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 32.922% |
| Inogen, Inc. | 126.69 Million USD | 95.621% |
| Spectral AI, Inc. | 7.88 Million USD | 29.594% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 184.163% |
| CVRx, Inc. | 33.03 Million USD | 83.208% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -8995.082% |
| Orthofix Medical Inc. | 486.27 Million USD | 98.859% |
| Venus Concept Inc. | 52.16 Million USD | 89.365% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -117.569% |
| Bioventus Inc. | 328.19 Million USD | 98.31% |
| BrainsWay Ltd. | 23.09 Million USD | 75.973% |
| Envoy Medical, Inc. | -473 Thousand USD | 1272.939% |
| electroCore, Inc. | 13.22 Million USD | 58.052% |
| IceCure Medical Ltd | 1.3 Million USD | -326.769% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 191.702% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 11820.466% |
| MaxCyte, Inc. | 36.54 Million USD | 84.819% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -1115.289% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -6422.455% |
| PAVmed Inc | -3.96 Million USD | 239.819% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 201.149% |
| RxSight, Inc. | 53.76 Million USD | 89.681% |
| Sight Sciences, Inc. | 69.17 Million USD | 91.98% |
| SI-BONE, Inc. | 109.42 Million USD | 94.93% |
| TELA Bio, Inc. | 40.11 Million USD | 86.169% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 65.12% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 96.348% |
| LivaNova PLC | 771.25 Million USD | 99.281% |
| 908 Devices Inc. | 25.32 Million USD | 78.09% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 98.211% |
| Nemaura Medical Inc. | -1.47 Million USD | 475.781% |
| NeuroPace, Inc. | 48.12 Million USD | 88.471% |
| LENSAR, Inc. | 21.1 Million USD | 73.715% |
| Apyx Medical Corporation | 14.12 Million USD | 60.714% |
| Cutera, Inc. | 41.49 Million USD | 86.629% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 69.947% |
| BioSig Technologies, Inc. | 18 Thousand USD | -30722.222% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 94.618% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 59.248% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.376% |
| Axonics, Inc. | 274.55 Million USD | 97.979% |
| Outset Medical, Inc. | 29 Million USD | 80.869% |
| IRIDEX Corporation | 21.8 Million USD | 74.559% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 92.191% |
| IRadimed Corporation | 50.15 Million USD | 88.939% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -1833.101% |
| INVO Bioscience, Inc. | 1.08 Million USD | -410.801% |
| Telesis Bio, Inc. | 16.95 Million USD | 67.268% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 95.081% |
| Varex Imaging Corporation | 256.9 Million USD | 97.84% |
| Quipt Home Medical Corp. | 163.84 Million USD | 96.614% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1466.502% |
| Pulmonx Corporation | 50.75 Million USD | 89.068% |
| Dynatronics Corporation | 7.63 Million USD | 27.334% |
| Modular Medical, Inc. | -768 Thousand USD | 822.396% |
| Semler Scientific, Inc. | 61.2 Million USD | 90.935% |
| InMode Ltd. | 411.34 Million USD | 98.651% |
| Bruker Corporation | 1.51 Billion USD | 99.634% |
| Cytosorbents Corporation | 22.39 Million USD | 75.223% |
| DexCom, Inc. | 2.28 Billion USD | 99.758% |
| Align Technology, Inc. | 2.71 Billion USD | 99.796% |
| Viveve Medical, Inc. | 620 Thousand USD | -794.839% |
| ZimVie Inc. | 290.38 Million USD | 98.089% |
| Movano Inc. | -158 Thousand USD | 3611.392% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 94.93% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -6422.455% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 98.491% |
| Profound Medical Corp. | 4.51 Million USD | -22.906% |
| Insulet Corporation | 1.15 Billion USD | 99.522% |
| enVVeno Medical Corporation | -546 Thousand USD | 1116.117% |
| Surmodics, Inc. | 93.05 Million USD | 94.038% |
| iCAD, Inc. | 14.53 Million USD | 61.833% |
| Nuwellis, Inc. | 4.98 Million USD | -11.339% |
| Biotricity, Inc. | 8.35 Million USD | 33.607% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 98.328% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 1645.159% |
| InspireMD, Inc. | 1.8 Million USD | -207.028% |
| PAVmed Inc. | -3.96 Million USD | 239.819% |
| BIOLASE, Inc. | 16.72 Million USD | 66.826% |
| Beyond Air, Inc. | -1.3 Million USD | 524.484% |
| FONAR Corporation | 45.14 Million USD | 87.709% |
| AxoGen, Inc. | 127.87 Million USD | 95.661% |
| Vivani Medical, Inc. | -357 Thousand USD | 1654.062% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 97.157% |
| Inari Medical, Inc. | 434.56 Million USD | 98.723% |
| UFP Technologies, Inc. | 112.22 Million USD | 95.056% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -44216.639% |
| Tenon Medical, Inc. | 1.24 Million USD | -347.059% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 6949.383% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -111.184% |
| AdaptHealth Corp. | 479.56 Million USD | 98.843% |
| Sintx Technologies, Inc. | 1.84 Million USD | -201.031% |
| NanoVibronix, Inc. | 1.53 Million USD | -260.963% |
| Quanterix Corporation | 70.64 Million USD | 92.147% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 1466.502% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 60.541% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 89.488% |
| TransMedics Group, Inc. | 154.09 Million USD | 96.4% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -24.59% |
| NeuroMetrix, Inc. | 3.94 Million USD | -40.548% |
| Hyperfine, Inc. | 4.75 Million USD | -16.628% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 94.814% |
| Biomerica, Inc. | 611 Thousand USD | -808.02% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 86.691% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 810.412% |
| Silk Road Medical, Inc | 127.08 Million USD | 95.634% |